Literature DB >> 11770842

Nuclear transport of photosensitizers during photosensitization and oxidative stress.

I A Patito1, C Rothmann, Z Malik.   

Abstract

The nuclear transport pathways of the photosensitizers meso-tetra(4-sulfonatophenyl)porphyrin (TPPS4) and meso-tetra(4-N-methylpyridyl)porphyrin (TMPyP) during photosensitization and oxidative stress were characterized in CT-26 murine colon carcinoma cells using fluorescence microscopy and multi-pixel spectral imaging. Prior to irradiation, TPPS4 and TMPyP localized mainly in the lysosomes, while irradiation or H2O2 treatment induced a relocalization into the nucleus and nucleoli. Flow cytometry analysis of isolated nuclei from the treated cells showed an increase in nuclear fluorescence accompanying the relocalization. Isolation and separation of the nuclear proteins according to molecular weight was performed using a sephadex G-100 column. The protein fractions exhibiting high fluorescence were separated by high performance liquid chromatography. Five major classes of proteins with a retention time of 1, 7, 11, 12 and 15 min were obtained. Each photosensitizer was associated with a distinct class of proteins. While TPPS4 fluorescence was detected in the protein fraction with a retention time of 11 min, TMPyP fluorescence was associated with a protein fraction having a retention time of 7 min. We conclude that although oxidative stress triggers entry into the nucleus of both TPPS4 and TMPyP, each sensitizer uses a distinct transport mechanism based on its chemical properties.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11770842     DOI: 10.1016/s0248-4900(01)01118-2

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  8 in total

1.  Pentalysine beta-carbonylphthalocyanine zinc: an effective tumor-targeting photosensitizer for photodynamic therapy.

Authors:  Zhuo Chen; Shanyong Zhou; Jincan Chen; Yicai Deng; Zhipu Luo; Hongwei Chen; Michael R Hamblin; Mingdong Huang
Journal:  ChemMedChem       Date:  2010-06-07       Impact factor: 3.466

2.  Toward a 3D cellular model for studying in vitro the outcome of photodynamic treatments: accounting for the effects of tissue complexity.

Authors:  Mireia Alemany-Ribes; María García-Díaz; Marta Busom; Santi Nonell; Carlos E Semino
Journal:  Tissue Eng Part A       Date:  2013-04-19       Impact factor: 3.845

3.  Potentiation by potassium iodide reveals that the anionic porphyrin TPPS4 is a surprisingly effective photosensitizer for antimicrobial photodynamic inactivation.

Authors:  Liyi Huang; Ahmed El-Hussein; Weijun Xuan; Michael R Hamblin
Journal:  J Photochem Photobiol B       Date:  2017-10-31       Impact factor: 6.252

4.  Multi-component redox system for selective and potent antineoplastic activity towards ovarian cancer cells.

Authors:  Debarshi Roy; Brenita Jenkins; Aqeeb Ali; Jacob R Herschmann; Michele Harris; Matibur Zamadar; Laken Simington; Odutayo Odunuga; Prakash Adhikari; Prabhakar Pradhan; Sanjay Sarkar; Mahesh Pattabiram; Bidisha Sengupta
Journal:  Biochem Biophys Res Commun       Date:  2022-01-06       Impact factor: 3.575

5.  A cell-targeted photodynamic nanomedicine strategy for head and neck cancers.

Authors:  Alyssa Master; Anthony Malamas; Rachna Solanki; Dana M Clausen; Julie L Eiseman; Anirban Sen Gupta
Journal:  Mol Pharm       Date:  2013-04-24       Impact factor: 4.939

6.  Photodynamic therapy: novel third-generation photosensitizers one step closer?

Authors:  L B Josefsen; R W Boyle
Journal:  Br J Pharmacol       Date:  2008-03-24       Impact factor: 8.739

7.  Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics.

Authors:  Leanne B Josefsen; Ross W Boyle
Journal:  Theranostics       Date:  2012-10-04       Impact factor: 11.556

8.  Metalloporphyrin Pd(T4) Exhibits Oncolytic Activity and Cumulative Effects with 5-ALA Photodynamic Treatment against C918 Cells.

Authors:  Brandon Leviskas; Tibor Valyi-Nagy; Gnanasekar Munirathinam; Matthew Bork; Klara Valyi-Nagy; Troy Skwor
Journal:  Int J Mol Sci       Date:  2020-01-20       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.